Fangyuan Zhou

发表

Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation.

Yichong Wang, Shenglan Yang, Luorui Shang, 2022, Journal of ethnopharmacology.

Emodin Attenuates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis Signaling Pathway In vitro and In vivo

Shenglan Yang, Luorui Shang, Yuhan Liu, 2021, Inflammation.

Integrated network pharmacology and experimental verification to investigate the mechanisms of YYFZBJS against colorectal cancer via CDK1/PI3K/Akt signaling

Shenglan Yang, Luorui Shang, Jin-Xiao Li, 2022, Frontiers in Oncology.

Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis

Shenglan Yang, Yu Fu, Luorui Shang, 2021, Frontiers in Medicine.

LINC00355:8 promotes cell proliferation and migration with invasion via the MiR-6777-3p/Wnt10b axis in Hepatocellular Carcinoma

Bin Wu, Xuan Xu, Yiming Lei, 2020, Journal of Cancer.

Screening of Therapeutic Targets for Pancreatic Cancer by Bioinformatics Methods

Z. Wan, J. Ou, Rui Ding, 2022, Hormone and Metabolic Research.

Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma

Bin Wu, Yiming Lei, Jie Jiang, 2018, EBioMedicine.

Survival benefit of thoracic radiotherapy plus EGFR-TKIs in patients with non-oligometastatic advanced non-small-cell lung cancer: a single-center retrospective study

Z. Yin, Bian Wu, Jing Huang, 2023, Therapeutic advances in medical oncology.

Dachengqi decoction ameliorates sepsis-induced liver injury by inhibiting the TGF-β1/Smad3 pathways

Yuhan Liu, G. Pan, Fangyuan Zhou, 2023, Journal of Traditional and Complementary Medicine.